1215336-46-1

Basic information

• Product Name: 7-(4-BroMobutoxy)-3,4-dihydroquinolin-2-one-d8
• Synonyms: 7-(4-BroMobutoxy)-3,4-dihydroquinolin-2-one-d8;7-(4-BroMobutoxy-d8)-3,4-dihydro-2(1H)-quinolinone
• CAS NO: 1215336-46-1
• Molecular Formula: C₁₃H₁₆BrNO₂
• Molecular Weight: 298.17564
• Product Categories: Aromatics;Heterocycles;Impurities;Intermediates & Fine Chemicals;Isotope Labelled Compounds;Pharmaceuticals
• Mol File: 1215336-46-1.mol
• Article Data: 0

Chemical Properties

• Appearance: /
• CAS DataBase Reference: 7-(4-BroMobutoxy)-3,4-dihydroquinolin-2-one-d8(CAS DataBase Reference)
• NIST Chemistry Reference: 7-(4-BroMobutoxy)-3,4-dihydroquinolin-2-one-d8(1215336-46-1)
• EPA Substance Registry System: 7-(4-BroMobutoxy)-3,4-dihydroquinolin-2-one-d8(1215336-46-1)

Safety Data

• Hazardous Substances Data: 1215336-46-1(Hazardous Substances Data)

Usage

Description

7-(4-BroMobutoxy)-3,4-dihydroquinolin-2-one-d8 is a chemical compound with the molecular formula C15H17BrO2. It is a derivative of dihydroquinolinone, featuring a bromine atom and a butoxy group attached to the molecule. 7-(4-BroMobutoxy)-3,4-dihydroquinolin-2-one-d8 is characterized by its unique structure and properties, which make it suitable for various applications in different industries.

Uses

Used in Pharmaceutical Industry:
7-(4-BroMobutoxy)-3,4-dihydroquinolin-2-one-d8 is used as a labeled impurity in the synthesis of Aripiprazole (A771000) for [application reason]. Aripiprazole is an antipsychotic medication used to treat schizophrenia, bipolar disorder, and major depressive disorder. The presence of this compound as an impurity helps in monitoring the purity and quality of the synthesized Aripiprazole, ensuring the safety and efficacy of the final drug product.
Used in Tablet Manufacturing:
7-(4-BroMobutoxy)-3,4-dihydroquinolin-2-one-d8 is also used as a degradation product in Aripiprazole tablets for [application reason]. During the manufacturing process of Aripiprazole tablets, this compound may be formed as a result of the degradation of the active pharmaceutical ingredient (API) under certain conditions. Monitoring the levels of this degradation product is crucial for maintaining the quality and safety of the tablets, as it can impact the drug's stability, efficacy, and potential side effects.

Downstream Products

• 1089115-04-7 aripiprazole-d₈